Stock listing
NASDAQ:EIDX Eidos Therapeutics Inc Stock
Follow Eidos Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:EIDX
$122.21 USD
Close on Jan 26, 2021 · No longer trades
- Lowest – highest close
- $9.20 – $131.58 USDSince Jun 20, 2018 · lowest Oct 11, 2018 · highest Dec 31, 2020
Delisted NASDAQ:EIDX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:EIDX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Eidos Therapeutics Inc on 6ix
- Decks
- 2 decks · latest Dec 29, 2020
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (December 2020) | Merger or acquisition | 29 slides | Dec 29, 2020 |
| Investor Presentation (September 2020) | Investor deck | 30 slides | Sep 29, 2020 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Rajeev M Shah Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past) | Director · Jun 19, 2018 – May 27, 2020 · Past |
| Cameron Turtle Other companies: Damora Therapeutics, Inc. (Board Director · Since at least Mar 23, 2026); Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); Spyre Therapeutics, Inc. (Chief Executive Officer · Since at least Jun 22, 2023); BridgeBio Pharma, Inc. (See Remarks · Jun 27, 2019 – Dec 28, 2020 · Past) | Chief Business Officer · Nov 5, 2018 – Jan 26, 2021 · Past |
| William Lis Other companies: Zai Lab Ltd. (Board Member · Since at least Jan 1, 2021); Jasper Therapeutics, Inc. (Director · Sep 24, 2021 – Oct 13, 2023 · Past); Portola Pharmaceuticals Inc (Chief Executive Officer, Director · May 21, 2013 – Jul 28, 2018 · Past) | Director · Dec 4, 2018 – Jan 26, 2021 · Past |
| Jonathan C. Fox Other companies: Edgewise Therapeutics, Inc. (Director · Since at least Mar 2, 2023); MyoKardia Inc (Chief Medical Officer · Oct 28, 2015 – Apr 29, 2016 · Past) | See Remarks · Jun 19, 2018 – Jan 26, 2021 · Past |
| Suzanne Sawochka Hooper Other companies: NGM Biopharmaceuticals Inc (Director · Apr 3, 2019 – Apr 5, 2024 · Past); Jazz Pharmaceuticals plc (EVP & General Counsel · Mar 12, 2012 – Feb 25, 2019 · Past) | Director · Aug 6, 2020 – Jan 26, 2021 · Past |
| Franco Valle Other companies: Biomea Fusion, Inc. (Chief Financial Officer · Jul 26, 2021 – Nov 30, 2024 · Past) | Senior Vice President, Finance · Oct 7, 2020 – Jan 26, 2021 · Past |
Log in to ask 6ix AI your own questions about Eidos Therapeutics Inc.